NO20042758L - Fremgangsmate for behandling av en pasient som krever analgesi. - Google Patents
Fremgangsmate for behandling av en pasient som krever analgesi.Info
- Publication number
- NO20042758L NO20042758L NO20042758A NO20042758A NO20042758L NO 20042758 L NO20042758 L NO 20042758L NO 20042758 A NO20042758 A NO 20042758A NO 20042758 A NO20042758 A NO 20042758A NO 20042758 L NO20042758 L NO 20042758L
- Authority
- NO
- Norway
- Prior art keywords
- patient requiring
- treating
- procedure
- analgesia
- devazepide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0201367.0A GB0201367D0 (en) | 2002-01-22 | 2002-01-22 | Composition |
| PCT/GB2003/000221 WO2003061632A1 (en) | 2002-01-22 | 2003-01-22 | Method of treatment of a patient requiring analgesia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20042758L true NO20042758L (no) | 2004-09-22 |
Family
ID=9929492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20042758A NO20042758L (no) | 2002-01-22 | 2004-06-30 | Fremgangsmate for behandling av en pasient som krever analgesi. |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1467718B1 (no) |
| JP (1) | JP2005521655A (no) |
| AT (1) | ATE310509T1 (no) |
| BR (1) | BR0307022A (no) |
| CA (1) | CA2473884A1 (no) |
| DE (1) | DE60302431T2 (no) |
| ES (1) | ES2253662T3 (no) |
| GB (1) | GB0201367D0 (no) |
| IL (1) | IL162768A0 (no) |
| MX (1) | MXPA04007030A (no) |
| NO (1) | NO20042758L (no) |
| PL (1) | PL371523A1 (no) |
| WO (1) | WO2003061632A1 (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0213198D0 (en) * | 2002-06-10 | 2002-07-17 | Ml Lab Plc | Method of treatment |
| GB0406280D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Chemical compounds |
| EP1928465A1 (en) | 2005-09-19 | 2008-06-11 | Arrow Therapeutics Limited | Benzodiazepine derivatives for treating hepatitis c infection |
| EP2089010A1 (en) | 2006-10-24 | 2009-08-19 | The John Hopkins University | Rapid release mini-tablets provide analgesia in laboratory animals |
| WO2009036287A1 (en) * | 2007-09-12 | 2009-03-19 | Elan Pharma International Limited | Dosing regimen |
| EP2611445B1 (en) * | 2010-09-03 | 2018-08-15 | Zoetis Belgium S.A. | High dose buprenorphine compositions and use as analgesic |
| US20120171277A1 (en) * | 2011-01-03 | 2012-07-05 | Royds Robert B | Abuse resistant transdermal drug delivery patch including a release-enhanced antagonist |
| US10729687B1 (en) | 2019-07-09 | 2020-08-04 | Orexo Ab | Pharmaceutical composition for nasal delivery |
| US10653690B1 (en) | 2019-07-09 | 2020-05-19 | Orexo Ab | Pharmaceutical composition for nasal delivery |
| PE20230382A1 (es) | 2020-05-18 | 2023-03-06 | Orexo Ab | Nueva composicion farmaceutica para administracion de farmacos |
| EP4236921A1 (en) | 2021-11-25 | 2023-09-06 | Orexo AB | Pharmaceutical composition comprising adrenaline |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1564039A (en) * | 1976-12-09 | 1980-04-02 | Berger F | Analgesic compositions comprising dextropropoxyphene and benzodiazepines |
| US5153191A (en) * | 1991-08-20 | 1992-10-06 | Warner-Lambert Company | Cholecystokinin antagonists useful for treating depression |
| GB9721746D0 (en) * | 1997-10-15 | 1997-12-10 | Panos Therapeutics Limited | Compositions |
-
2002
- 2002-01-22 GB GBGB0201367.0A patent/GB0201367D0/en not_active Ceased
-
2003
- 2003-01-22 WO PCT/GB2003/000221 patent/WO2003061632A1/en active IP Right Grant
- 2003-01-22 MX MXPA04007030A patent/MXPA04007030A/es not_active Application Discontinuation
- 2003-01-22 DE DE60302431T patent/DE60302431T2/de not_active Expired - Fee Related
- 2003-01-22 ES ES03708305T patent/ES2253662T3/es not_active Expired - Lifetime
- 2003-01-22 BR BR0307022-0A patent/BR0307022A/pt not_active IP Right Cessation
- 2003-01-22 PL PL03371523A patent/PL371523A1/xx not_active Application Discontinuation
- 2003-01-22 EP EP03708305A patent/EP1467718B1/en not_active Expired - Lifetime
- 2003-01-22 AT AT03708305T patent/ATE310509T1/de not_active IP Right Cessation
- 2003-01-22 IL IL16276803A patent/IL162768A0/xx unknown
- 2003-01-22 CA CA002473884A patent/CA2473884A1/en not_active Abandoned
- 2003-01-22 JP JP2003561577A patent/JP2005521655A/ja not_active Withdrawn
-
2004
- 2004-06-30 NO NO20042758A patent/NO20042758L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GB0201367D0 (en) | 2002-03-13 |
| EP1467718B1 (en) | 2005-11-23 |
| PL371523A1 (en) | 2005-06-27 |
| BR0307022A (pt) | 2004-11-03 |
| EP1467718A1 (en) | 2004-10-20 |
| DE60302431D1 (de) | 2005-12-29 |
| ATE310509T1 (de) | 2005-12-15 |
| CA2473884A1 (en) | 2003-07-31 |
| ES2253662T3 (es) | 2006-06-01 |
| IL162768A0 (en) | 2005-11-20 |
| WO2003061632A1 (en) | 2003-07-31 |
| DE60302431T2 (de) | 2006-07-27 |
| MXPA04007030A (es) | 2004-10-11 |
| JP2005521655A (ja) | 2005-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
| WO2005058233A3 (en) | Methods for treatment of acute pancreatitis | |
| WO2005044178A3 (en) | Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain | |
| UA88270C2 (ru) | Фармацевтический препарат и его применение для профилактики удара, диабета | |
| NZ592039A (en) | Combination therapy for the treatment of ocular neovascular disorders | |
| WO2000021515A3 (en) | Intranasal codeine for the rapid suppression of cough and rapid relief of pain | |
| DE69826644D1 (de) | Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker | |
| AU2003268144A1 (en) | Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist | |
| ATE292982T1 (de) | Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten | |
| WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
| WO2004039325A3 (en) | Treatment of pain with jnk inhibitors | |
| NO20042758L (no) | Fremgangsmate for behandling av en pasient som krever analgesi. | |
| NO994165L (no) | Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet | |
| WO2004037207A3 (en) | Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain | |
| BR0007452A (pt) | Uso de melagatrano ou de um derivado farmaceuticamente aceitável ou pró-droga do mesmo, método de tratamento de inflamação, e, formulação farmacêutica para uso no tratamento de inflamação | |
| TW200420290A (en) | Methods for the treatment, prevention and management of macular degeneration | |
| WO2002065989A3 (en) | Aminoglycoside treatment for lysosomal storage diseases | |
| TW200503683A (en) | Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain | |
| SE9902597D0 (sv) | New use | |
| MY126321A (en) | Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer. | |
| HUP0402326A2 (hu) | Gyógyszerkészítmény addikció megelőzésére fájdalom kezelésében | |
| NO984196D0 (no) | Fremgangsmåte for behandling av stoffmisbruk | |
| FI20010233A0 (fi) | Menetelmä sydämen vajaatoiminnan hoitoon | |
| NO20043774L (no) | The use of devazenide as analgesic agent | |
| DE60020550D1 (de) | Methode und mittel zur behandlung eines post-poliosyndroms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |